Skip to main content
profile image
Selected Works of Philip Mease, MD
Presentation
The Efficacy of Certolizumab Pegol over 4 Years in Psoriatic Arthritis Patients With and Without Concomitant Use of DMARDs. XLIV Congreso de la Sociedad Española de Reumatología, SER, A Coruña, Spain, May 2018
XLIV Congreso de la Sociedad Española de Reumatología, SER (2018)
  • Philip Mease, Providence St. Joseph Health
Link
Disciplines
Publication Date
May, 2018
Location
Spain
Citation Information
Philip Mease. "The Efficacy of Certolizumab Pegol over 4 Years in Psoriatic Arthritis Patients With and Without Concomitant Use of DMARDs. XLIV Congreso de la Sociedad Española de Reumatología, SER, A Coruña, Spain, May 2018" XLIV Congreso de la Sociedad Española de Reumatología, SER (2018)
Available at: http://works.bepress.com/philip-mease/136/